Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
Clinical trial NCT04334057 · COMPLETED
Trial details
- NCT number
- NCT04334057
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-31
- Primary completion
- 2023-11-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.